KPL vs SAIPARENT: Stock Comparison

Kwality Pharmaceuticals Ltd vs Sai Parenterals Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Kwality Pharmaceuticals Ltd is the larger company by market capitalisation. Kwality Pharmaceuticals Ltd shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Kwality Pharmaceuticals Ltd and Sai Parenterals Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KPL is more favourable on 7 of 11 scored metrics and SAIPARENT on 1These counts are context-free and are not an overall rating.

Key Differences

Market Cap
KPL is the larger company
₹2,692 Cr vs ₹2,402 Cr
P/E Ratio
KPL has a lower P/E
39.83x vs 169.94x
P/B Ratio
SAIPARENT has a lower P/B
4.94x vs 8.09x
EPS
KPL has higher earnings per share
₹64.9 vs ₹3.23
ROE
KPL has a higher ROE
22.8% vs 4.88%
ROCE
KPL has a higher ROCE
24.2% vs 5.97%
Net Margin
KPL has a higher net margin
13.39% vs 3.74%
Operating Margin
KPL has a higher operating margin
23.5% vs 10.2%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricKPLSAIPARENT
Live Price₹2,590.4₹547.4
Day Change-4.34%-2.21%
Volume26,34262,554
52-Week High₹2,890.3₹706
52-Week Low₹1,561₹400
Distance from 52W High-10.38%-22.46%

Valuation

MetricKPLSAIPARENT
Market Cap₹2,692 Cr₹2,402 Cr
P/E Ratio39.83x169.94x
P/B Ratio8.09x4.94x
EPS₹64.9₹3.23
Book Value₹320
Dividend Yield0%0%

Growth

MetricKPLSAIPARENT
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth35.8%
Qtr Profit Growth74.6%

Profitability & Leverage

MetricKPLSAIPARENT
ROE22.8%4.88%
ROCE24.2%5.97%
Net Margin13.39%3.74%
Operating Margin23.5%10.2%
Debt to Equity0.39x0.68x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricKPLSAIPARENT
Promoter Holding54.87% 0.04 pp51.16%
FII Holding2.79% 2.29 pp4.03% 1.7 pp
DII Holding0.36% 0.03 pp8.53% 4.33 pp
Public Holding41.98% 2.36 pp36.29% 6.03 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Kwality Pharmaceuticals Ltd and Sai Parenterals Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.